zynlonta - loncastuximab tesirine injection, powder, lyophilized, for solution
(Loncastuximab Tesirine)Adc Therapeutics America, Inc.
Usage: ZYNLONTA treats adults with relapsed or refractory large B-cell lymphoma, including DLBCL and high-grade B-cell lymphoma, after two or more prior lines of systemic therapy. Approved under accelerated approval based on overall response rate.